Chicago—Researchers have known for some time that the use of iodinated agents in contrast studies is associated with a risk of contrast-induced nephropathy (CIN) and that the risk is greater for those with compromised renal function. More recently, evidence has emerged that use of gadolinium-based agents is associated with a risk of another condition, nephrogenic systemic fibrosis (NSF), which has been reported only in persons with kidney disease.
Research presented at the Radiological Society of North America's annual meeting here in November reflects scientists' efforts to better understand these adverse effects and how to reduce the likelihood such problems will occur.
Graphic Jump Location
Use of gadolinium-based contrast agents in radiological studies is associated with a risk of nephrogenic systemic fibrosis, which has predominantly skin manifestations.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.